Global Information
회사소개 | 문의 | 비교리스트

세계의 기관지염 치료 시장(2020-2026년)

Global Bronchitis Treatment Market 2020-2026

리서치사 Orion Market Research Pvt Ltd
발행일 2020년 06월 상품 코드 949658
페이지 정보 영문
가격
US $ 3,600 ₩ 4,254,000 Unprintable PDF (Single User License)
US $ 4,800 ₩ 5,672,000 Printable PDF (Enterprise License)


세계의 기관지염 치료 시장(2020-2026년) Global Bronchitis Treatment Market 2020-2026
발행일 : 2020년 06월 페이지 정보 : 영문

세계의 기관지염 치료 시장은 예측기간 중 상당한 성장을 나타낼 것으로 예측됩니다. 고령자 인구 증가나 대기오염으로 천식 및 만성폐쇄성폐질환(COPD) 유병률이 증가하고 있으며, 이러한 요인이 시장 성장을 추진하고 있습니다. 약제 부문에서는 기관지확장제가 예측기간 중 높은 CAGR을 나타낼 전망입니다. 지역별로는 북미 지역이 큰 점유율을 차지할 것으로 예측되며, 고도로 성숙되고 개발된 의료 인프라를 가진 미국은 첨단 치료 솔루션 개발에 기여하고 있습니다. 또한 총인구 증가, 고령자 인구 증가, 산업화 가속과 그에 따른 대기오염 수준 상승 등의 요인으로 아시아태평양이 예측기간 중 높은 성장률을 나타낼 전망입니다.

세계의 기관지염 치료 시장을 조사했으며, 시장 정의와 개요, 시장 성장에 대한 각종 영향요인 분석, 관련 규제, 시장 규모 추정과 예측, 치료 구분 등 각종 세분화별 내역, 지역·주요 국가별 상세 분석, 경쟁 상황, 기업 점유율, 주요 기업 개요 등을 정리했습니다.

제1장 보고서 개요

제2장 시장 개요와 인사이트

  • 조사 범위
  • 애널리스트의 견해·현재 시장 동향
  • 규제

제3장 경쟁 상황

  • 기업 점유율 분석
  • 주요 전략 분석
  • 주요 기업 분석
    • 개요
    • 재무 분석
    • SWOT 분석
    • 최근의 전개

제4장 시장 영향요인

  • 성장 촉진요인
  • 성장 억제요인
  • 시장 기회

제5장 시장 분석과 예측 : 각종 부문별

  • 종류별
    • 약제
    • 산소요법

제6장 지역 분석

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 이탈리아
    • 스페인
    • 프랑스
    • 기타
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 기타
  • 기타 지역

제7장 기업 개요

  • Abbott Laboratories
  • Aurobindo Pharma Ltd.
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Cipla Ltd.
  • Dr Reddy's Laboratories Ltd.
  • GlaxoSmithKline PLC
  • Lupin Pharmaceuticals, Inc.
  • Mayne Pharma Group Ltd.
  • Merck & Co., Inc.
  • Mucinex(Reckitt Benckiser Group plc)
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
  • Teva Pharmaceutical Industries Ltd.
KSM 20.07.30

LIST OF TABLES

  • 1. GLOBAL BRONCHITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 2. GLOBAL BRONCHITIS TREATMENT DRUGS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 3. GLOBAL BRONCHITIS TREATMENT OXYGEN THERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)

4. GLOBAL BRONCHITIS TREATMENT OXYGEN THERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2019-

  • 5. GLOBAL BRONCHITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2019-2026 ($ MILLION)
  • 6. NORTH AMERICAN BRONCHITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 7. NORTH AMERICAN BRONCHITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 8. EUROPEAN BRONCHITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 9. EUROPEAN BRONCHITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 10. ASIA-PACIFIC BRONCHITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 11. ASIA-PACIFIC BRONCHITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 12. REST OF THE WORLD BRONCHITIS TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL BRONCHITIS TREATMENT MARKET SHARE BY TYPE, 2019 VS 2026 (%)
  • 2. GLOBAL BRONCHITIS TREATMENT MARKET SHARE BY GEOGRAPHY, 2019 VS 2026 (%)
  • 3. US BRONCHITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 4. CANADA BRONCHITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 5. UK BRONCHITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 6. FRANCE BRONCHITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 7. GERMANY BRONCHITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 8. ITALY BRONCHITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 9. SPAIN BRONCHITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 10. ROE BRONCHITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 11. INDIA BRONCHITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 12. CHINA BRONCHITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 13. JAPAN BRONCHITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 14. REST OF ASIA-PACIFIC BRONCHITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)
  • 15. REST OF THE WORLD BRONCHITIS TREATMENT MARKET SIZE, 2019-2026 ($ MILLION)

Global Bronchitis Treatment Market Size, Share & Trends Analysis Report by Type (Drugs (Antibiotics, Anti-Inflammatory Drugs, Bronchodilators, and Others) and Oxygen Therapy) and Forecast 2020-2026

The global bronchitis treatment market is projected to witness considerable growth during the forecast period. The major factors contributing to the growth of the market include the rising geriatric population and air pollution, which in turn, is increasing the prevalence of asthma and chronic obstructive pulmonary disease (COPD) across the globe. With the rise in these respiratory diseases, the incidence rate of bronchitis increases, which in turn, is offering growth to the market across the globe. The bronchitis treatment market is classified on the basis of type of treatment, which includes drugs and oxygen therapy. The drugs segment is further segregated into antibiotics, anti-inflammatory drugs, bronchodilators, and others. Among these types of treatments, the drugs find its significant application in the bronchitis treatment across the globe. In addition, the bronchodilator is estimated to project a considerable CAGR during the forecast period.

Geographically, the global bronchitis treatment market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. North America is expected to contribute a significant share in the global market. The US with a highly matured and developed healthcare infrastructure, contributes to the development of advanced treatment solution for bronchitis. The US has a high spending on healthcare R&D and high prevalence of asthma, which in turn, offers growth to the bronchitis treatment market in North America. In addition, Asia-Pacific is expected to project a considerable growth during the forecast period. This growth is backed by the rising population leading to the rise in geriatric population and increase in industrial sector in the region, especially in India, China, South Korea, and Japan. With the rise in industrialization, the level of air pollution will rise, which in turn, will augment the growth of the bronchitis treatment market in Asia-Pacific.

The global bronchitis treatment market is influenced by product development and advancements conducted by the market players. The key players of the bronchitis treatment market include Abbott Laboratories, Bayer AG, GlaxoSmithKline PLC, Novartis AG, Pfizer Inc., and Teva Pharmaceutical Industries Ltd. These players are playing a significant role in the growth of the bronchitis treatment market by providing various products and adopting several strategies such as merger and acquisition, partnerships and collaboration, technological development, and others.

Research Methodology

The market study of the global bronchitis treatment market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary sources include:

  • Financial reports of companies involved in the market
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog

The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

1. Global Bronchitis Treatment Market Research and Analysis by Type

The Report Covers:

  • Comprehensive research methodology of the global bronchitis treatment market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global bronchitis treatment market.
  • Insights about market determinants which are stimulating the global market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Bronchitis Treatment Market by Type
    • 5.1.1. Drugs
      • 5.1.1.1. Antibiotics
      • 5.1.1.2. Anti-inflammatory drugs
      • 5.1.1.3. Bronchodilators
      • 5.1.1.4. Others (Mucolytics)
    • 5.1.2. Oxygen Therapy

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Abbott Laboratories
  • 7.2. Aurobindo Pharma Ltd.
  • 7.3. Bayer AG
  • 7.4. Boehringer Ingelheim International GmbH
  • 7.5. Cipla Ltd.
  • 7.6. Dr Reddy's Laboratories Ltd.
  • 7.7. GlaxoSmithKline PLC
  • 7.8. Lupin Pharmaceuticals, Inc.
  • 7.9. Mayne Pharma Group Ltd.
  • 7.10. Merck & Co., Inc.
  • 7.11. Mucinex (Reckitt Benckiser Group plc)
  • 7.12. Novartis AG
  • 7.13. Pfizer Inc.
  • 7.14. Sanofi SA
  • 7.15. Teva Pharmaceutical Industries Ltd.
Back to Top
전화 문의
F A Q